More streamlined Harvest One to offer MMJ improved returns
MMJ Group Holdings Limited (ASX:MMJ) has released some important news regarding one of its investee companies, Harvest One Cannabis Inc. (TSX-V: HVT; OTCQX: HRVOF).
As part of management’s previously announced strategic review, Harvest One has entered into a definitive agreement to sell its United Greeneries’ licensed cannabis cultivation and processing businesses located in Duncan, British Columbia to Costa Canna Production Limited Liability Partnership and 626875 B.C. Ltd. for a total cash consideration of C$8.2 million.
Under the terms of the sale, Harvest One will also effect a licence agreement with the purchasers, which will provide Costa LLP, through its licensed subsidiary, the right to use certain licensed intellectual property of Harvest One to produce and distribute Cannabis 2.0 products in Canada in exchange for a royalty to be paid to Harvest One and, in turn, provide Harvest One with distribution for Cannabis 2.0 products in Canada.
Underlining the benefits of this transaction, Harvest One chief executive Andrew Bayfield said, “The agreement to sell our Duncan Facility and its related operations represents a strategic step forward for Harvest One, further divesting from its capital intensive cultivation activities and firmly establishing ourselves as a cannabis-focused CPG company.”
“We will continue to focus on expanding our core brands of LivReliefTM, Dream WaterTM and Satipharm together with the commercialisation of Cannabis 2.0 product offerings in Canada.
“When complete, this transaction will significantly improve the company’s overall cost structure and will provide liquidity to strengthen our balance sheet.
‘’We are continuing to take necessary and decisive measures to streamline our operations, lower our cost structure and reduce our cash burn.
‘’I am confident we are on the right path and this transaction serves to further reinforce the company’s plan to become cash flow positive in fiscal 2021.”
MMJ to benefit from new business structure and improved sales
These are very much the ingredients to maximising shareholder value, making this transaction highly beneficial to MMJ Group which owns approximately 55.5 million ordinary shares in the group with a market value of approximately C$5 million.
MMJ had also negotiated a secured loan of C$2 million on which it was earning interest at a rate of 15% per annum, a facility which will be repaid from the settlement of the Duncan facility.
From a broader perspective, MMJ benefits from its diversification and management’s ability to target emerging opportunities in the cannabis sector where it has been able to both growing the value of its investment portfolio while locking in one-off gains through divestments that can optimise shareholder returns.
Harvest One also provided a promising trading update for the March quarter which included quarter-on-quarter revenue growth of 88% as it generated income of $3.3 million.
Underlying earnings are heading in the right direction with the loss of $2.4 million down substantially on the $5 million loss in the previous quarter.
Importantly, there was a 22% reduction in cash operating expenses, a significant development as the company moves towards growing its top line.
It is worth noting that MMJ is trading at a significant discount to its net tangible asset per share value which stood at 20.5 cents as at May 31, 2020.
As mentioned previously, the company has focused on investing in a broad range of businesses across the sector and the performance of these is reflected in the net tangible asset value.
Consequently, the company could be one for investors who wish to target the sector without being solely reliant on the performance of one particular company.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.